These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 9821987
21. Retrospective study of vigabatrin and psychiatric behavioural disturbances. Wong IC. Epilepsy Res; 1995 Jul; 21(3):227-30. PubMed ID: 8536676 [Abstract] [Full Text] [Related]
22. Vigabatrin. Guberman A. Can J Neurol Sci; 1996 Nov; 23(4 Suppl 2):S13-7. PubMed ID: 8951215 [Abstract] [Full Text] [Related]
23. Vigabatrin in uncontrolled seizures: Belgian clinical experience. The Belgian Vigabatrin Evaluation Group. Lhoir A. Clin Neurol Neurosurg; 1994 Feb; 96(1):42-6. PubMed ID: 8187381 [Abstract] [Full Text] [Related]
24. Vigabatrin treatment in children. Fois A, Buoni S, Di Bartolo RM, Di Marco V, Mostardini R. Childs Nerv Syst; 1994 May; 10(4):244-8. PubMed ID: 7923235 [Abstract] [Full Text] [Related]
25. Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes. Bélanger S, Coulombe G, Carmant L. Epilepsia; 1998 Aug; 39(8):878-83. PubMed ID: 9701380 [Abstract] [Full Text] [Related]
26. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy. Dodrill CB, Arnett JL, Sommerville KW, Sussman NM. Epilepsia; 1995 Feb; 36(2):164-73. PubMed ID: 7821274 [Abstract] [Full Text] [Related]
30. Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options. Thibert RL, Conant KD, Braun EK, Bruno P, Said RR, Nespeca MP, Thiele EA. Epilepsia; 2009 Nov; 50(11):2369-76. PubMed ID: 19453717 [Abstract] [Full Text] [Related]
32. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood. McDonald DG, Najam Y, Keegan MB, Whooley M, Madden D, McMenamin JB. Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564 [Abstract] [Full Text] [Related]
33. Newer antiepileptic drugs. Towards an improved risk-benefit ratio. Patsalos PN, Sander JW. Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080 [Abstract] [Full Text] [Related]
34. Optimizing the indication of vigabatrin in children with refractory epilepsy. Lortie A, Chiron C, Dumas C, Mumford JP, Dulac O. J Child Neurol; 1997 Jun; 12(4):253-9. PubMed ID: 9203067 [Abstract] [Full Text] [Related]
35. Vigabatrin in unsatisfactory controlled epilepsies. Swiss Vigabatrin Study Group. Russ W. Schweiz Arch Neurol Psychiatr (1985); 1995 Jun; 146(2):55-9. PubMed ID: 7569836 [Abstract] [Full Text] [Related]
36. [Monotherapy with vigabatrin in the treatment of West's syndrome]. Rufo M, Santiago C, Castro E, Ocaña O. Rev Neurol; 1997 Sep; 25(145):1365-8. PubMed ID: 9377291 [Abstract] [Full Text] [Related]
37. Antiepileptics from gamma-aminobutyric acid. Satzinger G. Arzneimittelforschung; 1994 Mar; 44(3):261-6. PubMed ID: 8192689 [Abstract] [Full Text] [Related]
38. Open comparative long-term study of vigabatrin vs carbamazepine in newly diagnosed partial seizures in children. Zamponi N, Cardinali C. Arch Neurol; 1999 May; 56(5):605-7. PubMed ID: 10328256 [Abstract] [Full Text] [Related]
39. Prolonged vigabatrin treatment modifies developmental changes of GABA(A)-receptor binding in young children with epilepsy. Juhász C, Muzik O, Chugani DC, Shen C, Janisse J, Chugani HT. Epilepsia; 2001 Oct; 42(10):1320-6. PubMed ID: 11737167 [Abstract] [Full Text] [Related]
40. Inappropriate use of carbamazepine and vigabatrin in typical absence seizures. Parker AP, Agathonikou A, Robinson RO, Panayiotopoulos CP. Dev Med Child Neurol; 1998 Aug; 40(8):517-9. PubMed ID: 9746003 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]